Aquestive Therapeutics Inc

NASDAQ:AQST  
2.95
-0.35 (-10.61%)
Products

Aquestive Therapeutics Receives Notification From FDA That It Will Not Be Ready To Take Action By Dec 23, 2021 For Co's NDA For Libervant (Diazepam) Buccal Film

Published: 12/21/2021 04:03 GMT
Aquestive Therapeutics Inc (AQST) - Receives Notification From FDA That It Will Not Be Ready to Take Action by December 23, 2021 for Company's NDA for Libervant (diazepam) Buccal Film.
Currently Reaching Out to FDA to Seek Further Clarity Remain Fully Committed to Working Closely With FDA for Review.
FDA "still Considering Regulatory Issues Related to Approvability of Libervant, Will Not Be Ready to Take Action by Dec 23, 2021".